Related Experiment Video
Updated: Jan 28, 2026

A Tissue Displacement-based Contusive Spinal Cord Injury Model in Mice
Published on: June 18, 2017
MicroRNAs in contusion spinal cord injury: pathophysiology and clinical utility
1Department of Rehabilitation Medicine, Peking University Third Hospital, 49 North Garden Road, Beijing, 100191, People's Republic of China.
Abstract:
Spinal cord injury (SCI) in humans is a common central nervous system trauma. Pathophysiologically, SCI involves both primary and secondary damages. Therapeutically, targeting secondary damage including inflammation, neuropathic pain, apoptosis, demyelination, and glial reaction to promote functional benefits for SCI patients has long been considered a potential treatment strategy by neuroscientists and clinicians. As a type of small non-coding RNA, microRNAs (miRNAs) have been shown to play essential roles in the regulation of pathophysiologic processes of SCI and are considered to be an effective treatment method for SCI. Dysregulated expression of miRNAs is observed in SCI patients and animal models of SCI. Furthermore, miRNAs might also be used as biomarkers for diagnostic and prognostic purposes in SCI. Given contusion injury is the most clinically relevant type of SCI, this review mainly focuses on the role of miRNAs in the pathophysiology of contusion SCI and the putative utilization of miRNAs as diagnostic biomarkers and therapeutic targets for contusion SCI.
Insights
MicroRNAs (miRNAs) are key regulators in spinal cord injury (SCI) pathophysiology. This review explores their role in contusion SCI, highlighting their potential as diagnostic biomarkers and therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Spinal cord injury (SCI) is a significant central nervous system trauma with primary and secondary damage components.
- Targeting secondary damage, including inflammation and apoptosis, is a crucial therapeutic strategy for SCI.
- MicroRNAs (miRNAs), small non-coding RNAs, are increasingly recognized for their regulatory roles in SCI pathophysiology.
Purpose of the Study:
- To review the role of miRNAs in the pathophysiology of contusion SCI.
- To explore the potential of miRNAs as diagnostic biomarkers for SCI.
- To evaluate miRNAs as therapeutic targets for promoting functional recovery in SCI patients.
Main Methods:
- Literature review focusing on contusion SCI and miRNA involvement.
- Analysis of studies investigating miRNA expression in SCI patients and models.
- Examination of research on miRNA-based therapeutic strategies for SCI.
Main Results:
- Dysregulated miRNA expression is a hallmark of SCI, observed in both clinical cases and animal models.
- miRNAs are implicated in regulating key secondary injury processes such as inflammation, apoptosis, and glial scarring.
- Evidence suggests miRNAs can serve as valuable biomarkers for SCI diagnosis and prognosis.
Conclusions:
- MicroRNAs play critical roles in the complex pathophysiology of contusion SCI.
- miRNAs hold significant promise as diagnostic biomarkers and therapeutic agents for SCI.
- Further research into miRNA-based interventions could lead to improved functional outcomes for SCI patients.
Related Concept Videos
Spinal Cord
The Spinal Cord
Spinal Cord: Information Processing
Sensory Information Processing
Sensory information processing begins at the sensory receptors located in the skin and other tissues, which detect somatic sensory stimuli such as touch, temperature, or pain. These receptors function as catalysts, initiating...
Acute Kidney Injury II: Pathophysiology
MicroRNAs
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

